In the current work, we reported that clinically antiallergic drug desloratadine (DLT, Figure 1a) functioned as a selective antagonist of 5HT2AR and efficiently ameliorated AD pathology of APP/PS1 mice. The gene discussed is APP; the disease is Alzheimer disease.